IBRUTINIB EXPERIENCE IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA AND MANTLE CELL LYMPHOMA: SINGEL CENTER EXPERIENCE

被引：0
|
作者：
Uysal, A. [1 ]
Soyer, N. Akad [1 ]
Patir, P. [1 ]
Duran, M. [1 ]
Koseoglu, F. D. [1 ]
Sahin, F. [1 ]
Vural, F. [1 ]
Tombuloglu, M. [1 ]
Saydam, G. [1 ]
机构：
[1] Ege Univ, Sch Med, Dept Hematol, Izmir, Turkey
来源：
LEUKEMIA RESEARCH | 2016年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP-48
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [1] Ibrutinib Monotherapy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma: A Retrospective Single Center Experience from India
    Ahmed, Rayaz
    Bhurani, Dinesh
    Agarwal, Narendra
    Kapoor, Jyotsna
    Gurha, Neha
    Shah, Manan
    Narang, Prashant
    [J]. BLOOD, 2018, 132
  • [2] EXPERIENCE OF IBRUTINIB IN RELAPSED/REFRACTORY B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA AND MANTLE CELL LYMPHOMA IN A UK DISTRICT GENERAL HOSPITAL
    Lala, J.
    Smith, A.
    Millar, C.
    Fellows, G.
    Bryan, A.
    Addada, J.
    [J]. HAEMATOLOGICA, 2017, 102 : 720 - 721
  • [3] Ibrutinib for relapsed/refractory mantle cell lymphoma: 7-year experience
    Grilo, I. T.
    Couto, M. E.
    Freitas, J. F.
    Pereira, D. P.
    Moreira, C.
    Chacim, S.
    Domingues, N.
    Santo, A. E.
    Martins, A.
    Viterbo, L.
    Oliveira, I.
    Moreira, I.
    Mariz, J. M.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [4] IBRUTINIB FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA AND MANTLE CELL LYMPHOMA
    McDermott, J.
    Jimeno, A.
    [J]. DRUGS OF TODAY, 2014, 50 (04) : 291 - 300
  • [5] Clinical outcomes for ibrutinib in relapsed or refractory mantle cell lymphoma in real-world experience
    Jeon, Young-Woo
    Yoon, Seugyun
    Min, Gi June
    Park, Sung-Soo
    Park, Silvia
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Kim, Hee-Je
    Lee, Seok
    Min, Chang-Ki
    Lee, Jong Wook
    Cho, Seok-Goo
    [J]. CANCER MEDICINE, 2019, 8 (16): : 6860 - 6870
  • [6] Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
    Brown, J. R.
    Eichhorst, B.
    Hillmen, P.
    Jurczak, W.
    Kazmierczak, M.
    Lamanna, N.
    O'Brien, S. M.
    Tam, C. S.
    Qiu, L.
    Zhou, K.
    Simkovic, M.
    Mayer, J.
    Gillespie-Twardy, A.
    Ferrajoli, A.
    Ganly, P. S.
    Weinkove, R.
    Grosicki, S.
    Mital, A.
    Robak, T.
    Osterborg, A.
    Yimer, H. A.
    Salmi, T.
    Wang, M. -D. -Y.
    Fu, L.
    Li, J.
    Wu, K.
    Cohen, A.
    Shadman, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (04): : 319 - 332
  • [7] ALPINE: zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma
    Hillmen, Peter
    Brown, Jennifer R.
    Eichhorst, Barbara F.
    Lamanna, Nicole
    O'Brien, Susan M.
    Qiu, Lugui
    Salmi, Tommi
    Hilger, James
    Wu, Kenneth
    Cohen, Aileen
    Huang, Jane
    Tam, Constantine S.
    [J]. FUTURE ONCOLOGY, 2020, 16 (10) : 517 - 523
  • [8] IBRUTINIB IN THE MANAGEMENT OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A REAL-LIFE MONOCENTRIC EXPERIENCE
    Albi, E.
    Del Papa, B.
    Dorillo, E.
    Aureli, P.
    Cantelmi, M. G.
    Zei, T.
    Ostini, R. Iacucci
    Ciurnelli, R.
    Falzetti, F.
    Sportoletti, P.
    [J]. HAEMATOLOGICA, 2017, 102 : 123 - 123
  • [9] Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma
    Song, Yuqin
    Zhou, Keshu
    Yang, Shenmiao
    Hu, Jianda
    Zou, Dehui
    Gao, Sujun
    Pan, Ling
    Wang, Tingyu
    Yang, Haiyan
    Zhang, Huilai
    Zhou, Daobin
    Ji, Jie
    Xu, Wei
    Feng, Ru
    Jin, Jie
    Lv, Fangfang
    Huang, Haiwen
    Fan, Xiaosi
    Xu, Sheng
    Zhu, Jun
    [J]. INVESTIGATIONAL NEW DRUGS, 2023, 41 (04) : 606 - 616
  • [10] Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma
    Yuqin Song
    Keshu Zhou
    Shenmiao Yang
    Jianda Hu
    Dehui Zou
    Sujun Gao
    Ling Pan
    Tingyu Wang
    Haiyan Yang
    Huilai Zhang
    Daobin Zhou
    Jie Ji
    Wei Xu
    Ru Feng
    Jie Jin
    Fangfang Lv
    Haiwen Huang
    Xiaosi Fan
    Sheng Xu
    Jun Zhu
    [J]. Investigational New Drugs, 2023, 41 : 606 - 616
12345